579 related articles for article (PubMed ID: 27096953)
41. FBW7 is associated with prognosis, inhibits malignancies and enhances temozolomide sensitivity in glioblastoma cells.
Lin J; Ji A; Qiu G; Feng H; Li J; Li S; Zou Y; Cui Y; Song C; He H; Lu Y
Cancer Sci; 2018 Apr; 109(4):1001-1011. PubMed ID: 29427543
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of prolyl 4-hydroxylase, beta polypeptide (P4HB) attenuates temozolomide resistance in malignant glioma via the endoplasmic reticulum stress response (ERSR) pathways.
Sun S; Lee D; Ho AS; Pu JK; Zhang XQ; Lee NP; Day PJ; Lui WM; Fung CF; Leung GK
Neuro Oncol; 2013 May; 15(5):562-77. PubMed ID: 23444257
[TBL] [Abstract][Full Text] [Related]
43. Deferiprone Enhances Temozolomide Cytotoxicity in Glioma Cells.
Alexiou GA; Gerogianni P; Vartholomatos E; Kyritsis AP
Cancer Invest; 2016 Nov; 34(10):489-495. PubMed ID: 27768402
[TBL] [Abstract][Full Text] [Related]
44. Concomitant treatment with pertussis toxin plus temozolomide increases the survival of rats bearing intracerebral RG2 glioma.
Magaña-Maldonado R; Manoutcharian K; Hernández-Pedro NY; Rangel-López E; Pérez-De la Cruz V; Rodríguez-Balderas C; Sotelo J; Pineda B
J Cancer Res Clin Oncol; 2014 Feb; 140(2):291-301. PubMed ID: 24337403
[TBL] [Abstract][Full Text] [Related]
45. Temozolomide inhibits cellular growth and motility via targeting ERK signaling in glioma C6 cells.
Wang Y; Gao S; Wang W; Liang J
Mol Med Rep; 2016 Dec; 14(6):5732-5738. PubMed ID: 27878252
[TBL] [Abstract][Full Text] [Related]
46. Fluoxetine synergizes with temozolomide to induce the CHOP-dependent endoplasmic reticulum stress-related apoptosis pathway in glioma cells.
Ma J; Yang YR; Chen W; Chen MH; Wang H; Wang XD; Sun LL; Wang FZ; Wang DC
Oncol Rep; 2016 Aug; 36(2):676-84. PubMed ID: 27278525
[TBL] [Abstract][Full Text] [Related]
47. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells.
Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM
Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773
[TBL] [Abstract][Full Text] [Related]
48. Combination treatment with temozolomide and thalidomide inhibits tumor growth and angiogenesis in an orthotopic glioma model.
Son MJ; Kim JS; Kim MH; Song HS; Kim JT; Kim H; Shin T; Jeon HJ; Lee DS; Park SY; Kim YJ; Kim JH; Nam DH
Int J Oncol; 2006 Jan; 28(1):53-9. PubMed ID: 16327979
[TBL] [Abstract][Full Text] [Related]
49. Atorvastatin Promotes Cytotoxicity and Reduces Migration and Proliferation of Human A172 Glioma Cells.
Oliveira KA; Dal-Cim T; Lopes FG; Ludka FK; Nedel CB; Tasca CI
Mol Neurobiol; 2018 Feb; 55(2):1509-1523. PubMed ID: 28181188
[TBL] [Abstract][Full Text] [Related]
50. Potential application of temozolomide in mesenchymal stem cell-based TRAIL gene therapy against malignant glioma.
Kim SM; Woo JS; Jeong CH; Ryu CH; Jang JD; Jeun SS
Stem Cells Transl Med; 2014 Feb; 3(2):172-82. PubMed ID: 24436439
[TBL] [Abstract][Full Text] [Related]
51. Metformin and temozolomide act synergistically to inhibit growth of glioma cells and glioma stem cells in vitro and in vivo.
Yu Z; Zhao G; Xie G; Zhao L; Chen Y; Yu H; Zhang Z; Li C; Li Y
Oncotarget; 2015 Oct; 6(32):32930-43. PubMed ID: 26431379
[TBL] [Abstract][Full Text] [Related]
52. Inhibition of c-Jun N-terminal kinase enhances temozolomide-induced cytotoxicity in human glioma cells.
Ohba S; Hirose Y; Kawase T; Sano H
J Neurooncol; 2009 Dec; 95(3):307-316. PubMed ID: 19517066
[TBL] [Abstract][Full Text] [Related]
53. ABT-888 enhances cytotoxic effects of temozolomide independent of MGMT status in serum free cultured glioma cells.
Balvers RK; Lamfers ML; Kloezeman JJ; Kleijn A; Berghauser Pont LM; Dirven CM; Leenstra S
J Transl Med; 2015 Feb; 13():74. PubMed ID: 25886061
[TBL] [Abstract][Full Text] [Related]
54. Antitumor effect of fibrin glue containing temozolomide against malignant glioma.
Anai S; Hide T; Takezaki T; Kuroda J; Shinojima N; Makino K; Nakamura H; Yano S; Kuratsu J
Cancer Sci; 2014 May; 105(5):583-91. PubMed ID: 24673719
[TBL] [Abstract][Full Text] [Related]
55. Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status.
Chong DQ; Toh XY; Ho IA; Sia KC; Newman JP; Yulyana Y; Ng WH; Lai SH; Ho MM; Dinesh N; Tham CK; Lam PY
BMC Cancer; 2015 Apr; 15():255. PubMed ID: 25886314
[TBL] [Abstract][Full Text] [Related]
56. Aspirin inhibits the SHH/GLI1 signaling pathway and sensitizes malignant glioma cells to temozolomide therapy.
Ming J; Sun B; Li Z; Lin L; Meng X; Han B; Wang R; Wu P; Li J; Cai J; Jiang C
Aging (Albany NY); 2017 Apr; 9(4):1233-1247. PubMed ID: 28446712
[TBL] [Abstract][Full Text] [Related]
57. Temozolomide combined with PD-1 Antibody therapy for mouse orthotopic glioma model.
Dai B; Qi N; Li J; Zhang G
Biochem Biophys Res Commun; 2018 Jul; 501(4):871-876. PubMed ID: 29758196
[TBL] [Abstract][Full Text] [Related]
58. Tamoxifen in combination with temozolomide induce a synergistic inhibition of PKC-pan in GBM cell lines.
Balça-Silva J; Matias D; do Carmo A; Girão H; Moura-Neto V; Sarmento-Ribeiro AB; Lopes MC
Biochim Biophys Acta; 2015 Apr; 1850(4):722-32. PubMed ID: 25554223
[TBL] [Abstract][Full Text] [Related]
59. Dual mTORC1/2 blockade inhibits glioblastoma brain tumor initiating cells in vitro and in vivo and synergizes with temozolomide to increase orthotopic xenograft survival.
Luchman HA; Stechishin OD; Nguyen SA; Lun XQ; Cairncross JG; Weiss S
Clin Cancer Res; 2014 Nov; 20(22):5756-67. PubMed ID: 25316808
[TBL] [Abstract][Full Text] [Related]
60. Downregulation of HIF-1a sensitizes U251 glioma cells to the temozolomide (TMZ) treatment.
Tang JH; Ma ZX; Huang GH; Xu QF; Xiang Y; Li N; Sidlauskas K; Zhang EE; Lv SQ
Exp Cell Res; 2016 May; 343(2):148-158. PubMed ID: 27090014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
